Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway.

Youssef, Ramy F; Cost, Nicholas G; Darwish, Oussama M; Margulis, Vitaly

Youssef, Ramy F; Cost, Nicholas G; Darwish, Oussama M; Margulis, Vitaly.

Afiliação

Youssef RF; Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cost NG; Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Darwish OM; Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Margulis V; Division of Urologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Arab J Urol ; 10(2): 110-7, 2012 Jun.

Article em En | MEDLINE | ID: mdl-26558012

Palavras-chave

4E-BP1, eukaryotic initiation factor-binding protein-1; CA-9, carbonic anhydrase 9; HIF, hypoxia inducible factor; IRS-1, insulin receptor substrate-1; LDH, lactate dehydrogenase; Molecular markers; PI3k, phosphatidylinositol 3-kinase; Prognostic; Renal cell carcinoma; S6K1, S6 kinase 1; TKR, tyrosine kinase receptor; TSC, tuberous sclerosis complex; VEGF, vascular endothelial growth factor; VHL, von Hippel-Lindau; mTOR; mTOR, mammalian target of rapamycin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Arab J Urol Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google